ID   UN13A_RAT               Reviewed;        1735 AA.
AC   Q62768;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JAN-2024, entry version 172.
DE   RecName: Full=Protein unc-13 homolog A {ECO:0000305};
DE   AltName: Full=Munc13-1;
GN   Name=Unc13a {ECO:0000312|RGD:619722}; Synonyms=Unc13h1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7559667; DOI=10.1074/jbc.270.42.25273;
RA   Brose N., Hofmann K., Hata Y., Suedhof T.C.;
RT   "Mammalian homologues of Caenorhabditis elegans unc-13 gene define novel
RT   family of C2-domain proteins.";
RL   J. Biol. Chem. 270:25273-25280(1995).
RN   [2]
RP   INTERACTION WITH SYNTAXIN 1.
RX   PubMed=8999968; DOI=10.1074/jbc.272.4.2520;
RA   Betz A., Okamoto M., Benseler F., Brose N.;
RT   "Direct interaction of the rat unc-13 homologue Munc13-1 with the N
RT   terminus of syntaxin.";
RL   J. Biol. Chem. 272:2520-2526(1997).
RN   [3]
RP   INTERACTION WITH DOC2A.
RX   PubMed=9195900; DOI=10.1074/jbc.272.26.16081;
RA   Orita S., Naito A., Sakaguchi G., Maeda M., Igarashi H., Sasaki T.,
RA   Takai Y.;
RT   "Physical and functional interactions of Doc2 and Munc13 in Ca2+-dependent
RT   exocytotic machinery.";
RL   J. Biol. Chem. 272:16081-16084(1997).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF HIS-567.
RX   PubMed=9697857; DOI=10.1016/s0896-6273(00)80520-6;
RA   Betz A., Ashery U., Rickmann M., Augustin I., Neher E., Suedhof T.C.,
RA   Rettig J., Brose N.;
RT   "Munc13-1 is a presynaptic phorbol ester receptor that enhances
RT   neurotransmitter release.";
RL   Neuron 21:123-136(1998).
RN   [5]
RP   INTERACTION WITH DOC2A.
RX   PubMed=9736751; DOI=10.1073/pnas.95.19.11418;
RA   Mochida S., Orita S., Sakaguchi G., Sasaki T., Takai Y.;
RT   "Role of the Doc2 alpha-Munc13-1 interaction in the neurotransmitter
RT   release process.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:11418-11422(1998).
RN   [6]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=9895278; DOI=10.1042/bj3370363;
RA   Augustin I., Betz A., Herrmann C., Jo T., Brose N.;
RT   "Differential expression of two novel Munc13 proteins in rat brain.";
RL   Biochem. J. 337:363-371(1999).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH RIMS1.
RX   PubMed=11343654; DOI=10.1016/s0896-6273(01)00272-0;
RA   Betz A., Thakur P., Junge H.J., Ashery U., Rhee J.S., Scheuss V.,
RA   Rosenmund C., Rettig J., Brose N.;
RT   "Functional interaction of the active zone proteins Munc13-1 and RIM1 in
RT   synaptic vesicle priming.";
RL   Neuron 30:183-196(2001).
RN   [8]
RP   FUNCTION.
RX   PubMed=11792326; DOI=10.1016/s0092-8674(01)00635-3;
RA   Rhee J.S., Betz A., Pyott S., Reim K., Varoqueaux F., Augustin I.,
RA   Hesse D., Suedhof T.C., Takahashi M., Rosenmund C., Brose N.;
RT   "Beta phorbol ester- and diacylglycerol-induced augmentation of transmitter
RT   release is mediated by Munc13s and not by PKCs.";
RL   Cell 108:121-133(2002).
RN   [9]
RP   INTERACTION WITH BSN, AND IDENTIFICATION IN A COMPLEX WITH ERC2 AND RIMS1.
RX   PubMed=12163476; DOI=10.1083/jcb.200202083;
RA   Ohtsuka T., Takao-Rikitsu E., Inoue E., Inoue M., Takeuchi M.,
RA   Matsubara K., Deguchi-Tawarada M., Satoh K., Morimoto K., Nakanishi H.,
RA   Takai Y.;
RT   "Cast: a novel protein of the cytomatrix at the active zone of synapses
RT   that forms a ternary complex with RIM1 and Munc13-1.";
RL   J. Cell Biol. 158:577-590(2002).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=12871971; DOI=10.1074/jbc.m303203200;
RA   Sheu L., Pasyk E.A., Ji J., Huang X., Gao X., Varoqueaux F., Brose N.,
RA   Gaisano H.Y.;
RT   "Regulation of insulin exocytosis by Munc13-1.";
RL   J. Biol. Chem. 278:27556-27563(2003).
RN   [11]
RP   INTERACTION WITH BSN.
RX   PubMed=14734538; DOI=10.1083/jcb.200307101;
RA   Takao-Rikitsu E., Mochida S., Inoue E., Deguchi-Tawarada M., Inoue M.,
RA   Ohtsuka T., Takai Y.;
RT   "Physical and functional interaction of the active zone proteins, CAST,
RT   RIM1, and Bassoon, in neurotransmitter release.";
RL   J. Cell Biol. 164:301-311(2004).
RN   [12]
RP   DOMAIN, AND MUTAGENESIS OF GLN-1190; LEU-1279; ILE-1364; VAL-1603 AND
RP   ASP-1655.
RX   PubMed=16271475; DOI=10.1016/j.cub.2005.10.055;
RA   Stevens D.R., Wu Z.-X., Matti U., Junge H.J., Schirra C., Becherer U.,
RA   Wojcik S.M., Brose N., Rettig J.;
RT   "Identification of the minimal protein domain required for priming activity
RT   of Munc13-1.";
RL   Curr. Biol. 15:2243-2248(2005).
RN   [13]
RP   INTERACTION WITH RIMS2.
RX   PubMed=16052212; DOI=10.1038/sj.emboj.7600753;
RA   Dulubova I., Lou X., Lu J., Huryeva I., Alam A., Schneggenburger R.,
RA   Suedhof T.C., Rizo J.;
RT   "A Munc13/RIM/Rab3 tripartite complex: from priming to plasticity?";
RL   EMBO J. 24:2839-2850(2005).
RN   [14]
RP   INTERACTION WITH RIMS1, AND MUTAGENESIS OF THR-22; TYR-23; VAL-64; HIS-119
RP   AND ILE-121.
RX   PubMed=16704978; DOI=10.1074/jbc.m601421200;
RA   Andrews-Zwilling Y.S., Kawabe H., Reim K., Varoqueaux F., Brose N.;
RT   "Binding to Rab3A-interacting molecule RIM regulates the presynaptic
RT   recruitment of Munc13-1 and ubMunc13-2.";
RL   J. Biol. Chem. 281:19720-19731(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239; SER-241; SER-244 AND
RP   SER-255, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [16]
RP   STRUCTURE BY NMR OF 567-616.
RX   PubMed=15667202; DOI=10.1021/bi0476127;
RA   Shen N., Guryev O., Rizo J.;
RT   "Intramolecular occlusion of the diacylglycerol-binding site in the C1
RT   domain of munc13-1.";
RL   Biochemistry 44:1089-1096(2005).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.44 ANGSTROMS) OF 1-128, AND X-RAY CRYSTALLOGRAPHY
RP   (1.78 ANGSTROMS) OF 2-150 IN COMPLEX WITH RIMS2.
RX   PubMed=16732694; DOI=10.1371/journal.pbio.0040192;
RA   Lu J., Machius M., Dulubova I., Dai H., Suedhof T.C., Tomchick D.R.,
RA   Rizo J.;
RT   "Structural basis for a Munc13-1 homodimer to Munc13-1/RIM heterodimer
RT   switch.";
RL   PLoS Biol. 4:1159-1172(2006).
CC   -!- FUNCTION: Plays a role in vesicle maturation during exocytosis as a
CC       target of the diacylglycerol second messenger pathway. Involved in
CC       neurotransmitter release by acting in synaptic vesicle priming prior to
CC       vesicle fusion and participates in the activity-dependent refilling of
CC       readily releasable vesicle pool (RRP). Essential for synaptic vesicle
CC       maturation in most excitatory/glutamatergic but not inhibitory/GABA-
CC       mediated synapses. Facilitates neuronal dense core vesicles fusion as
CC       well as controls the location and efficiency of their synaptic release
CC       (By similarity). Also involved in secretory granule priming in insulin
CC       secretion. Plays a role in dendrite formation by melanocytes (By
CC       similarity). {ECO:0000250|UniProtKB:Q4KUS2,
CC       ECO:0000250|UniProtKB:Q9UPW8, ECO:0000269|PubMed:11343654,
CC       ECO:0000269|PubMed:11792326, ECO:0000269|PubMed:9697857}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00041};
CC   -!- SUBUNIT: Interacts with the N-termini of STX1A and/or STX1B1 and DOC2A
CC       (PubMed:8999968, PubMed:9195900, PubMed:9736751). Interacts with BSN
CC       (PubMed:12163476, PubMed:14734538). Interacts with RIMS1 which recruits
CC       UNC13A to the active zone (PubMed:11343654, PubMed:16704978). Forms
CC       homodimers via its first C2 domain. Also interacts via this domain with
CC       the zinc finger domain of RIMS2 (PubMed:16052212, PubMed:16732694).
CC       Part of a complex consisting of ERC2, RIMS1 and UNC13A
CC       (PubMed:12163476). Also part of a complex consisting of UNC13A, RIMS2
CC       and RAB3A. Interacts with FBXO45 (via SRY domain); leading to the
CC       degradation of UNC13A by the proteasome (By similarity).
CC       {ECO:0000250|UniProtKB:Q4KUS2, ECO:0000269|PubMed:11343654,
CC       ECO:0000269|PubMed:12163476, ECO:0000269|PubMed:14734538,
CC       ECO:0000269|PubMed:16052212, ECO:0000269|PubMed:16704978,
CC       ECO:0000269|PubMed:16732694, ECO:0000269|PubMed:8999968,
CC       ECO:0000269|PubMed:9195900, ECO:0000269|PubMed:9736751}.
CC   -!- INTERACTION:
CC       Q62768; Q9JIS1: Rims2; NbExp=4; IntAct=EBI-15584670, EBI-6972631;
CC       Q62768; Q62768: Unc13a; NbExp=4; IntAct=EBI-15584670, EBI-15584670;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell membrane; Peripheral membrane
CC       protein. Presynaptic cell membrane {ECO:0000269|PubMed:7559667};
CC       Peripheral membrane protein. Presynaptic active zone
CC       {ECO:0000269|PubMed:7559667}. Note=Translocated to the plasma membrane
CC       in response to phorbol ester binding.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q62768-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q62768-2; Sequence=VSP_011382;
CC       Name=3;
CC         IsoId=Q62768-3; Sequence=VSP_011383;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, with highest levels in the
CC       olfactory bulb, striatum, cerebral cortex, hippocampus and cerebellum.
CC       Also expressed in pancreatic islet cells. {ECO:0000269|PubMed:12871971,
CC       ECO:0000269|PubMed:7559667, ECO:0000269|PubMed:9895278}.
CC   -!- DEVELOPMENTAL STAGE: First detected at birth, after which expression
CC       level is steadily increasing until it reaches a plateau at P15.
CC       {ECO:0000269|PubMed:9895278}.
CC   -!- DOMAIN: The C2 domains are not involved in calcium-dependent
CC       phospholipid binding. {ECO:0000269|PubMed:16271475}.
CC   -!- DOMAIN: The C-terminal region containing both MHD domains and the third
CC       C2 domain is required for synaptic vesicle priming activity.
CC       {ECO:0000269|PubMed:16271475}.
CC   -!- SIMILARITY: Belongs to the unc-13 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U24070; AAC52266.1; -; mRNA.
DR   PIR; A57607; A57607.
DR   RefSeq; NP_074052.1; NM_022861.1.
DR   PDB; 1Y8F; NMR; -; A=567-616.
DR   PDB; 2CJS; X-ray; 1.78 A; A/B=2-150.
DR   PDB; 2CJT; X-ray; 1.44 A; A/B/C/D=1-128.
DR   PDB; 2KDU; NMR; -; B=458-492.
DR   PDB; 3SWH; X-ray; 2.65 A; A/B=1148-1407, A/B=1453-1531.
DR   PDB; 4Y21; X-ray; 2.90 A; A=942-1407, A=1453-1523.
DR   PDB; 5UE8; X-ray; 3.35 A; A/B=529-1407, A/B=1452-1531.
DR   PDB; 5UF7; X-ray; 2.90 A; A=942-1407, A=1453-1531.
DR   PDB; 6A30; X-ray; 2.79 A; A=944-1407, A=1453-1523.
DR   PDB; 6NYC; X-ray; 1.89 A; A=675-820.
DR   PDB; 6NYT; X-ray; 1.37 A; A=675-820.
DR   PDB; 7T7X; EM; 10.00 A; A=529-755, A=1401-1407, A=1452-1665.
DR   PDB; 7T81; EM; 10.00 A; A/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/Y=529-755, A/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/Y=1401-1407, A/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/Y=1452-1665.
DR   PDBsum; 1Y8F; -.
DR   PDBsum; 2CJS; -.
DR   PDBsum; 2CJT; -.
DR   PDBsum; 2KDU; -.
DR   PDBsum; 3SWH; -.
DR   PDBsum; 4Y21; -.
DR   PDBsum; 5UE8; -.
DR   PDBsum; 5UF7; -.
DR   PDBsum; 6A30; -.
DR   PDBsum; 6NYC; -.
DR   PDBsum; 6NYT; -.
DR   PDBsum; 7T7X; -.
DR   PDBsum; 7T81; -.
DR   AlphaFoldDB; Q62768; -.
DR   BMRB; Q62768; -.
DR   SMR; Q62768; -.
DR   BioGRID; 249207; 1.
DR   CORUM; Q62768; -.
DR   DIP; DIP-29191N; -.
DR   IntAct; Q62768; 3.
DR   STRING; 10116.ENSRNOP00000025162; -.
DR   CarbonylDB; Q62768; -.
DR   iPTMnet; Q62768; -.
DR   PhosphoSitePlus; Q62768; -.
DR   SwissPalm; Q62768; -.
DR   GeneID; 64829; -.
DR   KEGG; rno:64829; -.
DR   AGR; RGD:619722; -.
DR   CTD; 23025; -.
DR   RGD; 619722; Unc13a.
DR   eggNOG; KOG1011; Eukaryota.
DR   InParanoid; Q62768; -.
DR   OrthoDB; 5395569at2759; -.
DR   PhylomeDB; Q62768; -.
DR   EvolutionaryTrace; Q62768; -.
DR   PRO; PR:Q62768; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0044305; C:calyx of Held; ISO:RGD.
DR   GO; GO:0060076; C:excitatory synapse; IDA:BHF-UCL.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005798; C:Golgi-associated vesicle; IDA:UniProtKB.
DR   GO; GO:0031594; C:neuromuscular junction; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0048786; C:presynaptic active zone; IDA:UniProtKB.
DR   GO; GO:0098831; C:presynaptic active zone cytoplasmic component; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0097060; C:synaptic membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IBA:GO_Central.
DR   GO; GO:0043195; C:terminal bouton; HDA:ParkinsonsUK-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005516; F:calmodulin binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0019992; F:diacylglycerol binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005543; F:phospholipid binding; IEA:InterPro.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0000149; F:SNARE binding; IDA:RGD.
DR   GO; GO:0030507; F:spectrin binding; IPI:RGD.
DR   GO; GO:0019905; F:syntaxin binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0017075; F:syntaxin-1 binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0050435; P:amyloid-beta metabolic process; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0061789; P:dense core granule priming; IGI:SynGO-UCL.
DR   GO; GO:0060384; P:innervation; ISO:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IMP:RGD.
DR   GO; GO:0007528; P:neuromuscular junction development; ISO:RGD.
DR   GO; GO:0099011; P:neuronal dense core vesicle exocytosis; ISS:UniProtKB.
DR   GO; GO:0007269; P:neurotransmitter secretion; IDA:RGD.
DR   GO; GO:1903861; P:positive regulation of dendrite extension; ISO:RGD.
DR   GO; GO:1900451; P:positive regulation of glutamate receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001956; P:positive regulation of neurotransmitter secretion; ISO:RGD.
DR   GO; GO:0031915; P:positive regulation of synaptic plasticity; ISO:RGD.
DR   GO; GO:0099525; P:presynaptic dense core vesicle exocytosis; ISO:RGD.
DR   GO; GO:1902991; P:regulation of amyloid precursor protein catabolic process; ISO:RGD.
DR   GO; GO:0048172; P:regulation of short-term neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:0010807; P:regulation of synaptic vesicle priming; IDA:UniProtKB.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; ISO:RGD.
DR   GO; GO:0016081; P:synaptic vesicle docking; ISO:RGD.
DR   GO; GO:0016079; P:synaptic vesicle exocytosis; ISO:RGD.
DR   GO; GO:0016188; P:synaptic vesicle maturation; ISO:RGD.
DR   GO; GO:0016082; P:synaptic vesicle priming; IDA:RGD.
DR   CDD; cd20859; C1_Munc13-2-like; 1.
DR   CDD; cd08394; C2A_Munc13; 1.
DR   CDD; cd04027; C2B_Munc13; 1.
DR   CDD; cd08395; C2C_Munc13; 1.
DR   Gene3D; 1.10.357.50; -; 1.
DR   Gene3D; 1.20.58.1100; -; 1.
DR   Gene3D; 3.30.60.20; -; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 3.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR010439; MUN_dom.
DR   InterPro; IPR014770; Munc13_1.
DR   InterPro; IPR014772; Munc13_dom-2.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR027080; Unc-13.
DR   InterPro; IPR037302; Unc-13_C2B.
DR   PANTHER; PTHR10480; PROTEIN UNC-13 HOMOLOG; 1.
DR   PANTHER; PTHR10480:SF1; PROTEIN UNC-13 HOMOLOG A; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00168; C2; 3.
DR   Pfam; PF06292; MUN; 1.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00239; C2; 3.
DR   SMART; SM01145; DUF1041; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 3.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 1.
DR   PROSITE; PS50004; C2; 3.
DR   PROSITE; PS51258; MHD1; 1.
DR   PROSITE; PS51259; MHD2; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell membrane;
KW   Cell projection; Coiled coil; Cytoplasm; Differentiation; Exocytosis;
KW   Membrane; Metal-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Synapse; Zinc; Zinc-finger.
FT   CHAIN           1..1735
FT                   /note="Protein unc-13 homolog A"
FT                   /id="PRO_0000188574"
FT   DOMAIN          1..97
FT                   /note="C2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          672..796
FT                   /note="C2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          1106..1249
FT                   /note="MHD1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00587"
FT   DOMAIN          1358..1525
FT                   /note="MHD2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00588"
FT   DOMAIN          1558..1685
FT                   /note="C2 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   ZN_FING         566..616
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          185..458
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          319..370
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        203..224
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        253..276
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        277..317
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        318..369
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        427..455
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         580
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT   BINDING         583
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT   BINDING         597
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT   BINDING         600
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT   BINDING         608
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT   BINDING         616
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT   BINDING         705
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         705
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         711
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         757
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         757
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         759
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         759
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         776
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   MOD_RES         239
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         241
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         244
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         255
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         1434..1456
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_011382"
FT   VAR_SEQ         1541..1559
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_011383"
FT   MUTAGEN         22
FT                   /note="T->I: No effect on binding to RIMS1."
FT                   /evidence="ECO:0000269|PubMed:16704978"
FT   MUTAGEN         23
FT                   /note="Y->N: No effect on binding to RIMS1."
FT                   /evidence="ECO:0000269|PubMed:16704978"
FT   MUTAGEN         64
FT                   /note="V->M: No effect on binding to RIMS1."
FT                   /evidence="ECO:0000269|PubMed:16704978"
FT   MUTAGEN         119
FT                   /note="H->R: No effect on binding to RIMS1."
FT                   /evidence="ECO:0000269|PubMed:16704978"
FT   MUTAGEN         121
FT                   /note="I->N: Abolishes binding to RIMS1."
FT                   /evidence="ECO:0000269|PubMed:16704978"
FT   MUTAGEN         567
FT                   /note="H->K: Loss of phorbol-ester binding."
FT                   /evidence="ECO:0000269|PubMed:9697857"
FT   MUTAGEN         1190
FT                   /note="Q->R: Loss of binding to STX1B and priming activity;
FT                   when associated with P-1279 and E-1655."
FT                   /evidence="ECO:0000269|PubMed:16271475"
FT   MUTAGEN         1279
FT                   /note="L->P: Loss of binding to STX1B and priming activity;
FT                   when associated with R-1190 and E-1655."
FT                   /evidence="ECO:0000269|PubMed:16271475"
FT   MUTAGEN         1364
FT                   /note="I->F: Loss of binding to STX1B and priming
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:16271475"
FT   MUTAGEN         1603
FT                   /note="V->D: Loss of binding to STX1B and priming
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:16271475"
FT   MUTAGEN         1655
FT                   /note="D->E: Loss of binding to STX1B and priming activity;
FT                   when associated with R-1190 and P-1279."
FT                   /evidence="ECO:0000269|PubMed:16271475"
FT   STRAND          2..12
FT                   /evidence="ECO:0007829|PDB:2CJT"
FT   HELIX           17..19
FT                   /evidence="ECO:0007829|PDB:2CJT"
FT   STRAND          21..28
FT                   /evidence="ECO:0007829|PDB:2CJT"
FT   STRAND          31..34
FT                   /evidence="ECO:0007829|PDB:2CJT"
FT   STRAND          38..42
FT                   /evidence="ECO:0007829|PDB:2CJT"
FT   STRAND          44..53
FT                   /evidence="ECO:0007829|PDB:2CJT"
FT   STRAND          57..66
FT                   /evidence="ECO:0007829|PDB:2CJT"
FT   STRAND          72..81
FT                   /evidence="ECO:0007829|PDB:2CJT"
FT   HELIX           82..84
FT                   /evidence="ECO:0007829|PDB:2CJT"
FT   STRAND          95..98
FT                   /evidence="ECO:0007829|PDB:2CJT"
FT   STRAND          102..106
FT                   /evidence="ECO:0007829|PDB:2CJT"
FT   STRAND          109..111
FT                   /evidence="ECO:0007829|PDB:2CJT"
FT   STRAND          120..128
FT                   /evidence="ECO:0007829|PDB:2CJT"
FT   HELIX           135..150
FT                   /evidence="ECO:0007829|PDB:2CJS"
FT   HELIX           459..478
FT                   /evidence="ECO:0007829|PDB:2KDU"
FT   HELIX           487..490
FT                   /evidence="ECO:0007829|PDB:2KDU"
FT   HELIX           544..558
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   STRAND          569..572
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   STRAND          581..583
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   HELIX           590..592
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   STRAND          594..597
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   TURN            598..600
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   TURN            606..608
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   HELIX           609..611
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   HELIX           616..627
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   HELIX           630..650
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   HELIX           653..661
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   HELIX           666..680
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   STRAND          689..700
FT                   /evidence="ECO:0007829|PDB:6NYT"
FT   STRAND          712..718
FT                   /evidence="ECO:0007829|PDB:6NYT"
FT   STRAND          721..724
FT                   /evidence="ECO:0007829|PDB:6NYT"
FT   STRAND          735..744
FT                   /evidence="ECO:0007829|PDB:6NYT"
FT   STRAND          746..748
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   STRAND          750..757
FT                   /evidence="ECO:0007829|PDB:6NYT"
FT   HELIX           762..767
FT                   /evidence="ECO:0007829|PDB:6NYT"
FT   TURN            768..770
FT                   /evidence="ECO:0007829|PDB:6NYT"
FT   STRAND          774..784
FT                   /evidence="ECO:0007829|PDB:6NYT"
FT   HELIX           785..787
FT                   /evidence="ECO:0007829|PDB:6NYT"
FT   STRAND          790..797
FT                   /evidence="ECO:0007829|PDB:6NYT"
FT   STRAND          810..818
FT                   /evidence="ECO:0007829|PDB:6NYT"
FT   HELIX           828..843
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   TURN            844..850
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   TURN            869..871
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   HELIX           872..880
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   TURN            881..883
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   HELIX           886..897
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   HELIX           898..900
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   STRAND          901..903
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   HELIX           906..920
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   HELIX           932..936
FT                   /evidence="ECO:0007829|PDB:5UE8"
FT   HELIX           945..961
FT                   /evidence="ECO:0007829|PDB:6A30"
FT   HELIX           964..967
FT                   /evidence="ECO:0007829|PDB:6A30"
FT   HELIX           973..995
FT                   /evidence="ECO:0007829|PDB:6A30"
FT   HELIX           1006..1026
FT                   /evidence="ECO:0007829|PDB:6A30"
FT   HELIX           1028..1035
FT                   /evidence="ECO:0007829|PDB:6A30"
FT   STRAND          1039..1041
FT                   /evidence="ECO:0007829|PDB:4Y21"
FT   STRAND          1051..1053
FT                   /evidence="ECO:0007829|PDB:4Y21"
FT   HELIX           1059..1077
FT                   /evidence="ECO:0007829|PDB:6A30"
FT   TURN            1078..1082
FT                   /evidence="ECO:0007829|PDB:6A30"
FT   TURN            1087..1089
FT                   /evidence="ECO:0007829|PDB:6A30"
FT   HELIX           1092..1118
FT                   /evidence="ECO:0007829|PDB:6A30"
FT   HELIX           1123..1140
FT                   /evidence="ECO:0007829|PDB:6A30"
FT   TURN            1141..1143
FT                   /evidence="ECO:0007829|PDB:6A30"
FT   HELIX           1145..1148
FT                   /evidence="ECO:0007829|PDB:6A30"
FT   HELIX           1159..1187
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   STRAND          1192..1195
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   HELIX           1201..1218
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   HELIX           1224..1256
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   STRAND          1257..1260
FT                   /evidence="ECO:0007829|PDB:6A30"
FT   HELIX           1263..1285
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   TURN            1286..1290
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   HELIX           1293..1320
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   HELIX           1322..1337
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   HELIX           1353..1378
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   HELIX           1381..1402
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   STRAND          1454..1456
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   STRAND          1458..1461
FT                   /evidence="ECO:0007829|PDB:4Y21"
FT   HELIX           1472..1487
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   HELIX           1488..1490
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   HELIX           1495..1499
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   HELIX           1502..1513
FT                   /evidence="ECO:0007829|PDB:3SWH"
FT   TURN            1516..1518
FT                   /evidence="ECO:0007829|PDB:6A30"
SQ   SEQUENCE   1735 AA;  196356 MW;  BFE7D0467D258900 CRC64;
     MSLLCVGVKK AKFDGAQEKF NTYVTLKVQN VKSTTIAVRG SQPSWEQDFM FEINRLDLGL
     TVEVWNKGLI WDTMVGTVWI PLRTIRQSNE EGPGEWLTLD SQAIMADSEI CGTKDPTFHR
     ILLDAHFELP LDIPEEEARY WAKKLEQLNA MRDQDEYSFQ DQQDKPLPVP SSQCCNWNYF
     GWGEQNDDPD SAVDDRDSDY RSETSNSIPP PYYTTSQPNA SVHQYSVRPP PLGSRESYSD
     SMHSYEEFSE PRALSPTGSS RYASSGELSQ GSSQLSEDFD PDEHSLQGSE LDDERDRDSY
     HSCHSSVSYH KDSPRWDQDE EDLEDLEDLE DEELPEEEEL EEEELEEEEE LEEEELELEE
     EEEVPDDLAS YTQQEDTTVA EPKEFKRISF PTAAPQKEDK VSAVPIEAPD VSKGIPKAAT
     PEEKAAAECA QEAEPPKSEE SFRSREAEEG QEGQDAMSRA KANWLRAFNK VRMQLQEARG
     EGEMSKSLWF KGGPGGGLII IDSMPDIRKR KPIPLVSDLA MSLVQSRKAG ITSALASSTL
     NNEELKNHVY KKTLQALIYP ISCTTPHNFE VWTATTPTYC YECEGLLWGI ARQGMRCTEC
     GVKCHEKCQD LLNADCLQRA AEKSSKHGAE DRTQNIIMVL KDRMKIRERN KPEIFELIQE
     VFAVTKSAHT QQMKAVKQSV LDGTSKWSAK ISITVVCAQG LQAKDKTGSS DPYVTVQVGK
     TKKRTKTIYG NLNPVWEENF HFECHNSSDR IKVRVLDEDD DIKSRVKQRF KRESDDFLGQ
     TIIEVRTLSG EMDVWYNLDK RTDKSAVSGA IRLHISVEIK GEEKVAPYHV QYTCLHENLF
     HFVTDVQNNG VVKIPDAKGD DAWKVYYDET AQEIVDEFAM RYGVESIYQA MTHFACLSSK
     YMCPGVPAVM STLLANINAY YAHTTASTNV SASDRFAASN FGKERFVKLL DQLHNSLRID
     LSMYRNNFPA SSPERLQDLK STVDLLTSIT FFRMKVQELQ SPPRASQVVK DCVKACLNST
     YEYIFNNCHE LYGREYQTDP AKKGEVPPEE QGPSIKNLDF WSKLITLIVS IIEEDKNSYT
     PCLNQFPQEL NVGKISAEVM WSLFAQDMKY AMEEHDKHRL CKSADYMNLH FKVKWLYNEY
     VAELPTFKDR VPEYPAWFEP FVIQWLDENE EVSRDFLHGA LERDKKDGFQ QTSEHALFSC
     SVVDVFSQLN QSFEIIKKLE CPDPQIVGHY MRRFAKTISN VLLQYADIVS KDFASYCSKE
     KEKVPCILMN NTQQLRVQLE KMFEAMGGKE LDAEASGTLK ELQVKLNNVL DELSHVFATS
     FQPHIEECVR QMGDILSQVK GTGNVPASAC SSVAQDADNV LQPIMDLLDS NLTLFAKICE
     KTVLKRVLKE LWKLVMNTME RTIVLPPLTD QTMIGTLLRK HGKGLEKGRV KLPSHSDGTQ
     MIFNAAKELG QLSKLKDHMV REEAKSLTPK QCAVVELALD TIKQYFHAGG VGLKKTFLEK
     SPDLQSLRYA LSLYTQATDL LIKTFVQTQS AQVHGGKGTR FTLSEDVCPE MGSGVEDPVG
     EVSVHVELFT HPGTGEQKVT VKVVAANDLK WQTSGIFRPF IEVNIVGPQL SDKKRKFATK
     SKNNSWAPKY NESFQFSLSA DAGPECYELQ VCVKDYCFAR EDRTVELAVL QLRELAQRGS
     AACWLPLGRR IHMDDTGLTV LRILSQRSND EVAKEFVKLK SDTRSAEEGG AAPAP
//
